Answers are grounded in this paper and cite their sources.
The potent MCHR1 in vitro and in vivo antagonist activity of a series of cyclic tertiary alcohols derived from compound 2b is described. Subsequent pharmacokinetic and pharmacodynamic studies identified BMS-814580 (compound 10) as a highly efficacious antiobesity agent with a relatively clean in vitro and in vivo safety profile.
No takes yet. Share an insight, caveat, or question.
Ahmad et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: